Not applicableStudy completedNCT00617799
What this trial is testing
Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma
Who this might be right for
Kidney CancerMelanoma (Skin)
University of Nebraska 15